BLTP2 Gene

Name bridge-like lipid transfer protein family member 2
Description This gene was initially characterized in human as having high expression levels in breast carcinomas and breast cancer cell lines. This gene also has increased expression in prostrate cancer cells relative to normal prostrate tissues. Expression of this gene is negatively regulated by direct binding of the microRNA miR-195 to its 3' UTR. miR-195 has been shown to modulate the invasiveness of prostrate cancer cells and xenograft metastases by downgrading expression of this gene. In mouse, the protein encoded by this gene was identified as an antigen on acute monocytic leukemia cells. In human, alternative splicing results in multiple transcript variants encoding distinct isoforms; some of these isoforms are predicted to contain an RNA pol II promoter FMP27 protein domain and a Golgi-body-localization APT1 domain. [provided by RefSeq, Apr 2017]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have revealed that the gene originally identified as BCOX1—and in some reports as MLAA‐22—is overexpressed in breast carcinomas compared with normal tissues. In breast cancer, its mRNA is predominantly found in the cytoplasm of malignant epithelial cells, and its expression increases progressively from ductal in situ carcinomas to invasive and metastatic lesions. Elevated levels have been significantly associated with high histological grade, HER2 positivity, and triple‐negative status, suggesting that this gene plays a role in tumor progression and may serve as a marker of poor prognosis as well as a potential therapeutic target."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn prostate cancer, the deregulation of microRNAs has been shown to contribute to metastatic behavior. Specifically, the loss of miR‐195 expression leads to the de-repression of BCOX1, resulting in its aberrant upregulation. This deregulation contributes to enhanced cell proliferation, migration, and invasion, with in vivo models confirming that elevated BCOX1 levels promote tumor growth and metastasis. Such findings highlight its functional role in disease progression and support its investigation as a prognostic biomarker and therapeutic target in prostate cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional investigations have identified this gene as a novel tumor‐associated antigen in settings beyond breast and prostate cancers. Analysis of MLAA‐22, which maps to the same chromosomal region (17q11.2) and shares several molecular characteristics with BCOX1, has provided further insight into its antigenic properties and potential relevance in immunotherapeutic strategies, particularly in certain hematologic malignancies. Moreover, emerging data on the regulatory influence of circRNAs in lung cancer hint at complex post‐transcriptional networks that may intersect with BLTP2/BCOX1-related signaling pathways, although the direct role of this gene in lung cancer remains to be fully elucidated."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jin Song, Wanjun Yang, Ie-Ming Shih, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of BCOX1, a novel gene overexpressed in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagen.2005.09.017"}], "href": "https://doi.org/10.1016/j.bbagen.2005.09.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16289875"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16289875"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tong Liu, Xian-Yu Zhang, Xiao-Hui He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High levels of BCOX1 expression are associated with poor prognosis in patients with invasive ductal carcinomas of the breast."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0086952"}], "href": "https://doi.org/10.1371/journal.pone.0086952"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24489812"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24489812"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jia Guo, Min Wang, Xiuheng Liu "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-015-0209-7"}], "href": "https://doi.org/10.1186/s13046-015-0209-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26338045"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26338045"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Fu-Ling Zhou, Wang-Gang Zhang, Xin Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Bioinformatic analysis and identification for a novel antigen MLAA-22 in acute monocytic leukemia]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhongguo Shi Yan Xue Ye Xue Za Zhi (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18549609"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18549609"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Linxuan Wang, Wenjing Jin, Xiaochi Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circ_0000520 interacts with miR-512-5p to upregulate KIAA0100 to promote malignant behaviors in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-18-498"}], "href": "https://doi.org/10.14670/HH-18-498"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35866672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35866672"}]}]}]}
NCBI Gene ID 9703
API
Download Associations
Predicted Functions View BLTP2's ARCHS4 Predicted Functions.
Co-expressed Genes View BLTP2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View BLTP2's ARCHS4 Predicted Functions.

Functional Associations

BLTP2 has 2,676 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 25 datasets.

Click the + buttons to view associations for BLTP2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of BLTP2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of BLTP2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of BLTP2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
CM4AI U2OS Cell Map Protein Localization Assemblies assemblies containing BLTP2 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing BLTP2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with BLTP2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding BLTP2 protein from the GlyGen Glycosylated Proteins dataset.
GO Molecular Function Annotations 2025 molecular functions performed by BLTP2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of BLTP2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of BLTP2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by BLTP2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of BLTP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of BLTP2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of BLTP2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of BLTP2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of BLTP2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of BLTP2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of BLTP2 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of BLTP2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of BLTP2 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of BLTP2 gene from the Sci-Plex Drug Perturbation Signatures dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of BLTP2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of BLTP2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of BLTP2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with BLTP2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.